Product Recalls in New Jersey

Product recalls affecting New Jersey — including food, drugs, consumer products, medical devices, and vehicles distributed to New Jersey. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,841 recalls have been distributed to New Jersey in the last 12 months.

53,621 total recalls
2,841 in last 12 months

Showing 45614580 of 13,536 recalls

DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· QuVa Pharma, Inc.

Recalled Item: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Recalled by...

The Issue: Subpotent drug - Product did not contain drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Liquid Antacid Extra Strength Recalled by Glaxosmithkline Consumer...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· AVKARE Inc.

Recalled Item: Lamotrigine Tablets Recalled by AVKARE Inc. Due to Presence of Foreign...

The Issue: Presence of Foreign Substance consistent with granules from desiccant packs...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 28, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets Recalled by Lupin Pharmaceuticals Inc. Due to Product Mix...

The Issue: Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 27, 2020· Pfizer Inc.

Recalled Item: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg Recalled by...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 27, 2020· Apotex Inc.

Recalled Item: Metformin Hydrochloride Extended-Release Tablets Recalled by Apotex Inc. Due...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 26, 2020· Aurobindo Pharma USA Inc.

Recalled Item: Olanzapine Tablets Recalled by Aurobindo Pharma USA Inc. Due to Failed...

The Issue: Failed Impurities/ Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 26, 2020· Aurobindo Pharma USA Inc.

Recalled Item: Olanzapine Tablets Recalled by Aurobindo Pharma USA Inc. Due to Failed...

The Issue: Failed Impurities/ Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 26, 2020· UNICHEM PHARMACEUTICALS USA INC

Recalled Item: Clonidine Hydrochloride Tablets Recalled by UNICHEM PHARMACEUTICALS USA INC...

The Issue: Failed Impurities/Degradation Specifications: potential migration of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate Recalled by Teva Pharmaceuticals USA Due to...

The Issue: Some bottles may contain mixed strengths of the product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate Recalled by Teva Pharmaceuticals USA Due to...

The Issue: Some bottles may contain mixed strengths of the product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 22, 2020· Teva Pharmaceuticals USA

Recalled Item: Dextroamphetamine Saccharate Recalled by Teva Pharmaceuticals USA Due to...

The Issue: Some bottles may contain mixed strengths of the product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 22, 2020· Acella Pharmaceuticals, LLC

Recalled Item: NP Thyroid 90 Recalled by Acella Pharmaceuticals, LLC Due to Superpotent Drug.

The Issue: Superpotent Drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMay 22, 2020· The Harvard Drug Group

Recalled Item: Doxycycline Hyclate Tablets Recalled by The Harvard Drug Group Due to Failed...

The Issue: Failed Dissolution Specification: The dissolution test at the 24 month time...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund